Autoimmunity in psychotic disorders. Where we stand, challenges and opportunities.

[1]  K. Chandy,et al.  Antibodies and venom peptides: new modalities for ion channels , 2019, Nature Reviews Drug Discovery.

[2]  M. De Hert,et al.  Alpha7 acetylcholine receptor autoantibodies are rare in sera of patients diagnosed with schizophrenia or bipolar disorder , 2018, PloS one.

[3]  S. Hallermann,et al.  Human Autoantibodies against the AMPA Receptor Subunit GluA2 Induce Receptor Reorganization and Memory Dysfunction , 2018, Neuron.

[4]  P. Falkai,et al.  Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders , 2018, British Journal of Psychiatry.

[5]  M. Rosenfeld,et al.  Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor , 2018, Neurology.

[6]  B. Boeve,et al.  Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis , 2018, Annals of neurology.

[7]  M. Leboyer,et al.  Cell- and Single Molecule-Based Methods to Detect Anti-N-Methyl-D-Aspartate Receptor Autoantibodies in Patients With First-Episode Psychosis From the OPTiMiSE Project , 2017, Biological Psychiatry.

[8]  D. Kahn.  Voltage-gated Potassium Channel Antibody Autoimmune Encephalopathy Presenting With Isolated Psychosis in an Adolescent. , 2017, Journal of psychiatric practice.

[9]  Sindhu A. Idicula,et al.  Voltage-gated Potassium Channel Antibody Autoimmune Encephalopathy Presenting With Isolated Psychosis in an Adolescent. , 2017, Journal of psychiatric practice.

[10]  P. Santens,et al.  Anti-NMDA receptor encephalitis: still unknown and underdiagnosed by physicians and especially by psychiatrists? , 2017, Acta clinica Belgica.

[11]  S. Monaco,et al.  Persistence of anti-NMDAR antibodies in CSF after recovery from autoimmune encephalitis , 2017, Neurological Sciences.

[12]  H. Prüss.  Postviral autoimmune encephalitis: manifestations in children and adults , 2017, Current opinion in neurology.

[13]  Paul J. Harrison,et al.  CASPR2 autoantibodies are raised during pregnancy in mothers of children with mental retardation and disorders of psychological development but not autism , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[14]  J. Suvisaari,et al.  Anti-neuronal anti-bodies in patients with early psychosis , 2017, Schizophrenia Research.

[15]  C. Geis,et al.  Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System. , 2017, Physiological reviews.

[16]  H. Hwu,et al.  Seroprevalence survey of selective anti-neuronal autoantibodies in patients with first-episode schizophrenia and chronic schizophrenia , 2017, Schizophrenia Research.

[17]  B. Lennox,et al.  Synaptic and Neuronal Autoantibody-Associated Psychiatric Syndromes: Controversies and Hypotheses , 2017, Front. Psychiatry.

[18]  J. Honnorat,et al.  Autoimmune encephalitis in psychiatric institutions: current perspectives , 2016, Neuropsychiatric disease and treatment.

[19]  Benjamin R. Rost,et al.  Human cerebrospinal fluid monoclonal N-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis. , 2016, Brain : a journal of neurology.

[20]  S. Reitan,et al.  Prevalence of serum anti-neuronal autoantibodies in patients admitted to acute psychiatric care , 2016, Psychological Medicine.

[21]  T. Minami,et al.  Anti-NMDA receptor encephalitis presenting as an acute psychotic episode misdiagnosed as dissociative disorder: a case report , 2016, JA Clinical Reports.

[22]  J. Haro,et al.  Anti-NMDAR antibodies in new-onset psychosis. Positive results in an HIV-infected patient , 2016, Brain, Behavior, and Immunity.

[23]  B. Lennox,et al.  Emerging psychiatric syndromes associated with antivoltage-gated potassium channel complex antibodies , 2016, Journal of Neurology, Neurosurgery & Psychiatry.

[24]  K. Sankaranarayanan,et al.  Understanding autoimmunity: The ion channel perspective. , 2016, Autoimmunity reviews.

[25]  A. Vincent,et al.  Pathogenesis of myasthenia gravis: update on disease types, models, and mechanisms , 2016, F1000Research.

[26]  J. Dalmau,et al.  Human neurexin-3α antibodies associate with encephalitis and alter synapse development , 2016, Neurology.

[27]  W. Tang,et al.  Autoantibodies Specifically Against β1 Adrenergic Receptors and Adverse Clinical Outcome in Patients With Chronic Systolic Heart Failure in the β-Blocker Era: The Importance of Immunoglobulin G3 Subclass. , 2016, Journal of cardiac failure.

[28]  K. Bechter.  CSF diagnostics in psychiatry – present status – future projects , 2016 .

[29]  K. Rostásy,et al.  Autoimmune post–herpes simplex encephalitis of adults and teenagers , 2015, Neurology.

[30]  C. Hammer,et al.  The brain as immunoprecipitator of serum autoantibodies against N‐Methyl‐D‐aspartate receptor subunit NR1 , 2015, Annals of neurology.

[31]  L. Tebartz van Elst,et al.  Immunological findings in psychotic syndromes: a tertiary care hospital's CSF sample of 180 patients , 2015, Front. Hum. Neurosci..

[32]  R. Dale,et al.  Autoantibodies in movement and psychiatric disorders: updated concepts in detection methods, pathogenicity, and CNS entry , 2015, Annals of the New York Academy of Sciences.

[33]  D. Kahn,et al.  A Case of Anti-NMDA Receptor Encephalitis Treated with ECT. , 2015, Journal of psychiatric practice.

[34]  S. Kushner,et al.  Autoimmune Encephalitis in Postpartum Psychosis. , 2015, The American journal of psychiatry.

[35]  R. Kahn,et al.  Absence of N-Methyl-D-Aspartate Receptor IgG Autoantibodies in Schizophrenia: The Importance of Cross-Validation Studies. , 2015, JAMA psychiatry.

[36]  L. Castro,et al.  A patient with a long history of relapsing psychosis and mania presenting with anti-NMDA receptor encephalitis ten years after first episode , 2015, Dementia & neuropsychologia.

[37]  Y. Altunkaynak,et al.  A case of NMDAR encephalitis misdiagnosed as postpartum psychosis and neuroleptic malignant syndrome , 2015, Neurological Sciences.

[38]  R. Heekin,et al.  Anti-NMDA Receptor Encephalitis in a Patient with Previous Psychosis and Neurological Abnormalities: A Diagnostic Challenge , 2015, Case reports in psychiatry.

[39]  Timothy J Keyes,et al.  Structural and functional features of central nervous system lymphatics , 2015, Nature.

[40]  M. Frye,et al.  Psychiatric Autoimmunity: N-Methyl-D-Aspartate Receptor IgG and Beyond. , 2015, Psychosomatics.

[41]  A. Pandurangi,et al.  Anti-N-Methyl-D-Aspartate Receptor Encephalitis Presenting With Psychiatric Symptoms. , 2015, The Journal of neuropsychiatry and clinical neurosciences.

[42]  A. Hofer,et al.  Neurology Issues in Schizophrenia , 2015, Current Psychiatry Reports.

[43]  J. Dalmau,et al.  Antibodies to Inhibitory Synaptic Proteins in Neurological Syndromes Associated with Glutamic Acid Decarboxylase Autoimmunity , 2015, PloS one.

[44]  R. Dale,et al.  Antibodies to Surface Dopamine-2 Receptor and N-Methyl-D-Aspartate Receptor in the First Episode of Acute Psychosis in Children , 2015, Biological Psychiatry.

[45]  B. Bogerts,et al.  N-Methyl-d-aspartate receptor autoantibodies in schizophrenia and affective disorders , 2015, Schizophrenia Research.

[46]  H. Heinze,et al.  Complement-associated neuronal loss in a patient with CASPR2 antibody–associated encephalitis , 2015, Neurology: Neuroimmunology & Neuroinflammation.

[47]  K. Rostásy,et al.  Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response. , 2015, JAMA neurology.

[48]  S. Shergill,et al.  Prevalence of serum N-methyl-d-aspartate receptor autoantibodies in refractory psychosis , 2015, The British journal of psychiatry : the journal of mental science.

[49]  A. Vincent,et al.  An 11-year retrospective experience of antibodies against the voltage-gated potassium channel (VGKC) complex from a tertiary neurological centre , 2015, Journal of Neurology.

[50]  J. Honnorat,et al.  Immunoglobulin G antibodies to the N‐Methyl‐D‐aspartate receptor are distinct from immunoglobulin A and immunoglobulin M responses , 2015, Annals of neurology.

[51]  Gillian Dekkers,et al.  IgG Subclasses and Allotypes: From Structure to Effector Functions , 2014, Front. Immunol..

[52]  G. Spalletta,et al.  Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood–brain barrier integrity , 2014, Molecular Psychiatry.

[53]  G. Nogales-Gadea,et al.  Proteasome Inhibition with Bortezomib Depletes Plasma Cells and Specific Autoantibody Production in Primary Thymic Cell Cultures from Early-Onset Myasthenia Gravis Patients , 2014, The Journal of Immunology.

[54]  G. Spalletta,et al.  Seroprevalence of autoantibodies against brain antigens in health and disease , 2014, Annals of neurology.

[55]  A. Vincent,et al.  Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes , 2014, Brain : a journal of neurology.

[56]  S. Satake,et al.  Identification and Characterization of GABAA Receptor Autoantibodies in Autoimmune Encephalitis , 2014, The Journal of Neuroscience.

[57]  Alex Iranzo,et al.  A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study , 2014, The Lancet Neurology.

[58]  P. Girardi,et al.  Neurological Soft Signs Discriminate Schizophrenia from Bipolar Disorder , 2014, Journal of psychiatric practice.

[59]  W. Mason,et al.  Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies , 2014, The Lancet Neurology.

[60]  F. Ducray,et al.  Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis , 2014, Neurology.

[61]  J. Dalmau,et al.  Herpes simplex virus encephalitis is a trigger of brain autoimmunity , 2014, Annals of neurology.

[62]  R. Balice-Gordon,et al.  Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study , 2014, The Lancet Neurology.

[63]  D. Schoepf,et al.  Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions , 2014, European Archives of Psychiatry and Clinical Neuroscience.

[64]  J. Leckman,et al.  Brain Human Monoclonal Autoantibody from Sydenham Chorea Targets Dopaminergic Neurons in Transgenic Mice and Signals Dopamine D2 Receptor: Implications in Human Disease , 2013, The Journal of Immunology.

[65]  Masahiko Watanabe,et al.  Autoantibodies to Epilepsy-Related LGI1 in Limbic Encephalitis Neutralize LGI1-ADAM22 Interaction and Reduce Synaptic AMPA Receptors , 2013, The Journal of Neuroscience.

[66]  J. Britton,et al.  GABAB receptor autoantibody frequency in service serologic evaluation , 2013, Neurology.

[67]  E. Pasquale,et al.  Eph receptor signaling and ephrins. , 2013, Cold Spring Harbor perspectives in biology.

[68]  J. Dalmau,et al.  Frequency and characteristics of isolated psychiatric episodes in anti–N-methyl-d-aspartate receptor encephalitis. , 2013, JAMA neurology.

[69]  J. Schott,et al.  Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[70]  M. Daly,et al.  Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis , 2013, The Lancet.

[71]  A. Vincent,et al.  Developments in autoimmune channelopathies. , 2013, Autoimmunity reviews.

[72]  S. Markx,et al.  Anti-NMDA receptor encephalitis: a cause of acute psychosis and catatonia. , 2013, Journal of psychiatric practice.

[73]  M. Skalej,et al.  Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis. , 2013, JAMA psychiatry.

[74]  G. Nogales-Gadea,et al.  Antibodies to contactin‐1 in chronic inflammatory demyelinating polyneuropathy , 2013, Annals of neurology.

[75]  C. Klein,et al.  Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping. , 2013, JAMA neurology.

[76]  B. Rudy,et al.  Encephalitis and antibodies to dipeptidyl‐peptidase–like protein‐6, a subunit of Kv4.2 potassium channels , 2013, Annals of neurology.

[77]  T. Kašpárek,et al.  Dynamics of neurological soft signs and its relationship to clinical course in patients with first-episode schizophrenia , 2012, Psychiatry Research.

[78]  P. Fallon,et al.  Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[79]  K. Berman,et al.  Serum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophrenia. , 2012, The American journal of psychiatry.

[80]  H. Shaaban,et al.  Anti-NMDA-receptor encephalitis presenting as postpartum psychosis in a young woman, treated with rituximab , 2012, Annals of Saudi medicine.

[81]  A. Vincent,et al.  VGKC‐complex antibody mediated encephalitis presenting with psychiatric features and neuroleptic malignant syndrome – further expanding the phenotype , 2012, Developmental medicine and child neurology.

[82]  F. Georges,et al.  Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis. , 2012, Brain : a journal of neurology.

[83]  Wei Li,et al.  Mutation analysis of the NRXN1 gene in a Chinese autism cohort. , 2012, Journal of psychiatric research.

[84]  K. Jellinger,et al.  Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. , 2012, Brain : a journal of neurology.

[85]  R. Schwartz.  Historical overview of immunological tolerance. , 2012, Cold Spring Harbor perspectives in biology.

[86]  I. Rosenzweig,et al.  Abnormalities in thalamic neurophysiology in schizophrenia: Could psychosis be a result of potassium channel dysfunction? , 2012, Neuroscience & Biobehavioral Reviews.

[87]  D. Pinto,et al.  Rare deletions at the neurexin 3 locus in autism spectrum disorder. , 2012, American journal of human genetics.

[88]  F. Moore,et al.  Paraneoplastic encephalitis presenting as postpartum psychosis. , 2011, Psychosomatics.

[89]  B. Crespi,et al.  Comparative immunogenetics of autism and schizophrenia , 2011, Genes, brain, and behavior.

[90]  A. Vincent,et al.  Limbic encephalitis presenting as a post-partum psychiatric condition , 2011, Journal of the Neurological Sciences.

[91]  J. Horváth,et al.  Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis , 2011, Neurology.

[92]  Jim van Os,et al.  Late onset autism and anti-NMDA-receptor encephalitis , 2011, The Lancet.

[93]  L. Crepaldi,et al.  Altered levels of glutamatergic receptors and Na+/K+ ATPase-α1 in the prefrontal cortex of subjects with schizophrenia , 2011, Schizophrenia Research.

[94]  M. Beadsworth,et al.  Voltage-gated, potassium-channel antibody-associated limbic encephalitis presenting as acute psychosis. , 2011, The Journal of neuropsychiatry and clinical neurosciences.

[95]  Laurent Mottron,et al.  Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia , 2011, Human Genetics.

[96]  Mary Cannon,et al.  The prevalence of psychosis in epilepsy; a systematic review and meta-analysis , 2014, BMC Psychiatry.

[97]  H. Vause,et al.  Anti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatment. , 2011, The American journal of psychiatry.

[98]  R. Balice-Gordon,et al.  Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis , 2011, The Lancet Neurology.

[99]  Peter B. Jones,et al.  Disease-relevant autoantibodies in first episode schizophrenia , 2010, Journal of Neurology.

[100]  A. Gomez,et al.  Antibody effector mechanisms in myasthenia gravis—Pathogenesis at the neuromuscular junction , 2010, Autoimmunity.

[101]  R. Balice-Gordon,et al.  Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series , 2010, The Lancet Neurology.

[102]  A. Vincent,et al.  Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia , 2010, Brain : a journal of neurology.

[103]  R. Balice-Gordon,et al.  Anti-N-methyl-D-aspartate receptor encephalitis during pregnancy. , 2010, Archives of neurology.

[104]  Xiaoyu Peng,et al.  Cellular and Synaptic Mechanisms of Anti-NMDA Receptor Encephalitis , 2010, The Journal of Neuroscience.

[105]  M. Mühlethaler,et al.  Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. , 2010, The Journal of clinical investigation.

[106]  D. Friedman,et al.  Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen , 2010, The Lancet Neurology.

[107]  Glinda S Cooper,et al.  Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. , 2009, Journal of autoimmunity.

[108]  M. Rosenfeld,et al.  Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma , 2009, Acta Neuropathologica.

[109]  P. Striano,et al.  Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: A study on 233 patients , 2009, Journal of Neuroimmunology.

[110]  B. Volpe,et al.  Losing your nerves? Maybe it's the antibodies , 2009, Nature Reviews Immunology.

[111]  X. Bossuyt.  Clinical performance characteristics of a laboratory test. A practical approach in the autoimmune laboratory. , 2009, Autoimmunity reviews.

[112]  A. Sawa,et al.  Schizophrenia and epilepsy: Is there a shared susceptibility? , 2009, Neuroscience Research.

[113]  T. Rispens,et al.  Immunoglobulin G4: an odd antibody , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[114]  Michelle J Chandley,et al.  Increased antibodies for the α7 subunit of the nicotinic receptor in schizophrenia , 2009, Schizophrenia Research.

[115]  R. Kalb,et al.  AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location , 2009, Annals of neurology.

[116]  Elvira Bramon,et al.  Disruption of the neurexin 1 gene is associated with schizophrenia. , 2009, Human molecular genetics.

[117]  Xiaoyu Peng,et al.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies , 2008, The Lancet Neurology.

[118]  Michael K. Hutchinson,et al.  PROGRESSIVE ENCEPHALOMYELITIS, RIGIDITY, AND MYOCLONUS: A NOVEL GLYCINE RECEPTOR ANTIBODY , 2008, Neurology.

[119]  David G. Amaral,et al.  Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism , 2008, Brain, Behavior, and Immunity.

[120]  P. Parren,et al.  Anti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange , 2007, Science.

[121]  J. Honnorat,et al.  Orphanet Journal of Rare Diseases Paraneoplastic Neurological Syndromes Disease Name Definition and Diagnostic Criteria , 2007 .

[122]  Josep Dalmau,et al.  Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratoma , 2007, Annals of neurology.

[123]  Charles E. Schwartz,et al.  High frequency of neurexin 1β signal peptide structural variants in patients with autism , 2006, Neuroscience Letters.

[124]  P. Fletcher,et al.  Psychiatric presentation of voltage-gated potassium channel antibody-associated encephalopathy , 2006, British Journal of Psychiatry.

[125]  Karl J. Friston,et al.  Synaptic Plasticity and Dysconnection in Schizophrenia , 2006, Biological Psychiatry.

[126]  B. Volpe,et al.  Immunity and behavior: antibodies alter emotion. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[127]  K. Heekeren,et al.  Psychological Effects of (S)-Ketamine and N,N-Dimethyltryptamine (DMT): A Double-Blind, Cross-Over Study in Healthy Volunteers , 2005, Pharmacopsychiatry.

[128]  Nenad Blau,et al.  Autoantibodies to folate receptors in the cerebral folate deficiency syndrome. , 2005, The New England journal of medicine.

[129]  R. Jonsson,et al.  Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors , 2005, European journal of neurology.

[130]  Ichiro Nakashima,et al.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis , 2004, The Lancet.

[131]  B. Volpe,et al.  Cognition and immunity; antibody impairs memory. , 2004, Immunity.

[132]  A. Chan,et al.  Pathogenic roles of B cells in human autoimmunity; insights from the clinic. , 2004, Immunity.

[133]  R. A. Davidoff,et al.  GABAA receptor subunit mRNA expression in cultured embryonic and adult human dorsal root ganglion neurons. , 2004, Brain research. Developmental brain research.

[134]  M. Rossor,et al.  Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. , 2004, Brain : a journal of neurology.

[135]  A. Vincent,et al.  Antibodies in Myasthenia Gravis and Related Disorders , 2003, Annals of the New York Academy of Sciences.

[136]  M. Rossor,et al.  Amnesia, cerebral atrophy, and autoimmunity , 2003, The Lancet.

[137]  A. Blamire,et al.  Maternal neuronal antibodies associated with autism and a language disorder , 2003, Annals of neurology.

[138]  H. Johansen-Berg,et al.  Maternal antibody-mediated dyslexia? Evidence for a pathogenic serum factor in a mother of two dyslexic children shown by transfer to mice using behavioural studies and magnetic resonance spectroscopy , 2002, Journal of Neuroimmunology.

[139]  K. Kullander,et al.  Mechanisms and functions of eph and ephrin signalling , 2002, Nature Reviews Molecular Cell Biology.

[140]  T. Pawson,et al.  The Receptor Tyrosine Kinase EphB2 Regulates NMDA-Dependent Synaptic Function , 2001, Neuron.

[141]  J. Oger,et al.  Potassium channel antibodies in two patients with reversible limbic encephalitis , 2001, Annals of neurology.

[142]  Robin M. Murray,et al.  Schizophrenia and HLA: a review , 2001, Schizophrenia Research.

[143]  Michael E Greenberg,et al.  EphB Receptors Interact with NMDA Receptors and Regulate Excitatory Synapse Formation , 2000, Cell.

[144]  J. McNamara,et al.  GluR3 Autoantibodies Destroy Neural Cells in a Complement-Dependent Manner Modulated by Complement Regulatory Proteins , 2000, The Journal of Neuroscience.

[145]  A. Malhotra,et al.  Clozapine Blunts N-Methyl-d-Aspartate Antagonist-Induced Psychosis: A Study with Ketamine , 1997, Biological Psychiatry.

[146]  B. Rapoport,et al.  Recombinant thyroid peroxidase-specific Fab converted to immunoglobulin G (IgG) molecules: evidence for thyroid cell damage by IgG1, but not IgG4, autoantibodies. , 1997, The Journal of clinical endocrinology and metabolism.

[147]  Herbert Weingartner,et al.  NMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy Volunteers , 1996, Neuropsychopharmacology.

[148]  J. Olney,et al.  Glutamate receptor dysfunction and schizophrenia. , 1995, Archives of general psychiatry.

[149]  J. G. van Dijk,et al.  Acquired neuromyotonia: Evidence for autoantibodies directed against K+ channels of peripheral nerves , 1995, Annals of neurology.

[150]  G. L. Curran,et al.  Macromolecular permeability across the blood nerve and blood brain barriers Joseph F. Poduslo, Geoffry L. Curran, Carole T. Berg. Molecular Neurobiology Laboratory, Mayo Foundation, Rochester, MN 55905 USA , 1994, Neurobiology of Aging.

[151]  L. Moiola,et al.  Myasthenia gravis. CD4+ T epitopes on the embryonic gamma subunit of human muscle acetylcholine receptor. , 1992, The Journal of clinical investigation.

[152]  V. Singh,et al.  Detection of maternal antibodies in infantile autism. , 1990, Journal of the American Academy of Child and Adolescent Psychiatry.

[153]  P. De Camilli,et al.  Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. , 1988, The New England journal of medicine.

[154]  L. DeLisi,et al.  Quantitative Determination of Immunoglobulins in CSF and Plasma of Chronic Schizophrenic Patients , 1981, British Journal of Psychiatry.

[155]  J. Hammerstad,et al.  The origin and turnover rates of cerebrospinal fluid albumin and gamma-globulin in man. , 1970, Journal of the neurological sciences.

[156]  G. Rosenbaum,et al.  Study of a new schizophrenomimetic drug; sernyl. , 1959, A.M.A. archives of neurology and psychiatry.

[157]  Paul J. Harrison,et al.  Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a case-control study. , 2017, The lancet. Psychiatry.

[158]  R. Balice-Gordon,et al.  Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice. , 2015, Brain : a journal of neurology.

[159]  H. Dosch,et al.  Limiting dilution analysis of the B cell compartment in human bone marrow , 1986, European journal of immunology.